Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Amenorrhea × Inositol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 31 Insulin Resistance 5 Infertility 5 Hyperandrogenism 3 Anovulation 3 Pre-Eclampsia 2 Metabolic Syndrome 2 Infertility, Female 2 Glucose Intolerance 2 Diabetes, Gestational 2 Carcinoma, Non-Small-Cell Lung 2 Weight Loss 1 Thyroid Nodule 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Premature Birth 1 Precancerous Conditions 1 Oligomenorrhea 1 Lung Neoplasms 1 Inflammation 1 Colonic Neoplasms 1 Amenorrhea 1

Interventions

Musculoskeletal Manipulations 2 drospirenone and ethinyl estradiol combination 1 Tamoxifen 1 Radiotherapy 1 Postoperative Period 1 Metformin 1 Mastectomy, Segmental 1 Mastectomy, Modified Radical 1 Inositol 1 Flutamide 1 Epirubicin 1 Docetaxel 1 Cyproterone acetate, ethinyl estradiol drug combination 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06800170 2026-01-06

HP-phD_Adolesc

Lo.Li.Pharma s.r.l

Phase NA Recruiting

Amenorrhea, Oligomenorrhea, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡